CN105051022B - 用于制备普瑞巴林的方法和中间体 - Google Patents

用于制备普瑞巴林的方法和中间体 Download PDF

Info

Publication number
CN105051022B
CN105051022B CN201480018083.5A CN201480018083A CN105051022B CN 105051022 B CN105051022 B CN 105051022B CN 201480018083 A CN201480018083 A CN 201480018083A CN 105051022 B CN105051022 B CN 105051022B
Authority
CN
China
Prior art keywords
acid
reaction
formula
alkyl
added
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201480018083.5A
Other languages
English (en)
Chinese (zh)
Other versions
CN105051022A (zh
Inventor
S·德巴尔热
D·T·厄德曼
P·M·奥尼尔
R·库玛
M·J·卡尔米洛维兹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ireland Pharmaceuticals
Original Assignee
Pfizer Ireland Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ireland Pharmaceuticals filed Critical Pfizer Ireland Pharmaceuticals
Priority to CN201710882505.9A priority Critical patent/CN107556273A/zh
Priority to CN201710882572.0A priority patent/CN107746834A/zh
Publication of CN105051022A publication Critical patent/CN105051022A/zh
Application granted granted Critical
Publication of CN105051022B publication Critical patent/CN105051022B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/18Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/001Amines; Imines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B53/00Asymmetric syntheses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/12Formation of amino and carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/74Unsaturated compounds containing —CHO groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/66Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1096Transferases (2.) transferring nitrogenous groups (2.6)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/005Amino acids other than alpha- or beta amino acids, e.g. gamma amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02Oxygen as only ring hetero atoms
    • C12P17/04Oxygen as only ring hetero atoms containing a five-membered hetero ring, e.g. griseofulvin, vitamin C
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04Formation of amino groups in compounds containing carboxyl groups
    • C07C227/06Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid
    • C07C227/08Formation of amino groups in compounds containing carboxyl groups by addition or substitution reactions, without increasing the number of carbon atoms in the carbon skeleton of the acid by reaction of ammonia or amines with acids containing functional groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/08Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to hydrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/60Two oxygen atoms, e.g. succinic anhydride
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Furan Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CN201480018083.5A 2013-03-27 2014-03-25 用于制备普瑞巴林的方法和中间体 Expired - Fee Related CN105051022B (zh)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CN201710882505.9A CN107556273A (zh) 2013-03-27 2014-03-25 用于制备普瑞巴林的方法和中间体
CN201710882572.0A CN107746834A (zh) 2013-03-27 2014-03-25 用于制备普瑞巴林的方法和中间体

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361805786P 2013-03-27 2013-03-27
US61/805,786 2013-03-27
PCT/IB2014/060140 WO2014155291A1 (en) 2013-03-27 2014-03-25 Process and intermediates for the preparation of pregabalin

Related Child Applications (2)

Application Number Title Priority Date Filing Date
CN201710882572.0A Division CN107746834A (zh) 2013-03-27 2014-03-25 用于制备普瑞巴林的方法和中间体
CN201710882505.9A Division CN107556273A (zh) 2013-03-27 2014-03-25 用于制备普瑞巴林的方法和中间体

Publications (2)

Publication Number Publication Date
CN105051022A CN105051022A (zh) 2015-11-11
CN105051022B true CN105051022B (zh) 2017-10-27

Family

ID=50483187

Family Applications (3)

Application Number Title Priority Date Filing Date
CN201480018083.5A Expired - Fee Related CN105051022B (zh) 2013-03-27 2014-03-25 用于制备普瑞巴林的方法和中间体
CN201710882505.9A Pending CN107556273A (zh) 2013-03-27 2014-03-25 用于制备普瑞巴林的方法和中间体
CN201710882572.0A Pending CN107746834A (zh) 2013-03-27 2014-03-25 用于制备普瑞巴林的方法和中间体

Family Applications After (2)

Application Number Title Priority Date Filing Date
CN201710882505.9A Pending CN107556273A (zh) 2013-03-27 2014-03-25 用于制备普瑞巴林的方法和中间体
CN201710882572.0A Pending CN107746834A (zh) 2013-03-27 2014-03-25 用于制备普瑞巴林的方法和中间体

Country Status (21)

Country Link
US (1) US20160024540A1 (enExample)
EP (2) EP3216863A1 (enExample)
JP (1) JP2016516744A (enExample)
KR (1) KR20150121202A (enExample)
CN (3) CN105051022B (enExample)
AU (2) AU2014240833B2 (enExample)
BR (2) BR112015024859A2 (enExample)
CA (1) CA2905411A1 (enExample)
CY (1) CY1118945T1 (enExample)
DK (1) DK2978748T3 (enExample)
ES (1) ES2630128T3 (enExample)
HU (1) HUE034834T2 (enExample)
IL (1) IL241438A0 (enExample)
MX (1) MX2015013589A (enExample)
PL (1) PL2978748T3 (enExample)
PT (1) PT2978748T (enExample)
RU (2) RU2017125261A (enExample)
SG (1) SG11201506998XA (enExample)
SI (1) SI2978748T1 (enExample)
WO (1) WO2014155291A1 (enExample)
ZA (1) ZA201506798B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102341494B (zh) 2009-01-08 2014-10-15 科德克希思公司 转氨酶多肽
WO2016075082A1 (en) 2014-11-10 2016-05-19 Sandoz Ag Stereoselective reductive amination of alpha-chiral aldehydes using omega-transaminases for the synthesis of precursors of pregabalin and brivaracetam
WO2016140799A1 (en) * 2015-03-03 2016-09-09 Ark Diagnostics, Inc. Pregabalin immunoassays
CA3064574A1 (en) 2017-06-14 2018-12-20 Codexis, Inc. Engineered transaminase polypeptides for industrial biocatalysis
MX2021000278A (es) 2018-07-09 2021-03-31 Merck Sharp & Dohme Llc Sintesis enzimatica de analogos de nucleosido de 4'-etinilo.
CN111004102B (zh) * 2019-12-23 2022-11-04 万华化学集团股份有限公司 一种制备光学活性香茅醛的方法及用于该方法的催化剂
CN118772033A (zh) * 2024-06-11 2024-10-15 中国科学院成都生物研究所 一种普瑞巴林三聚体的合成方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1649827A (zh) * 2002-04-30 2005-08-03 沃尼尔·朗伯有限责任公司 高度官能化γ-丁内酰胺和γ-氨基酸的制备方法
WO2008127646A2 (en) * 2007-04-11 2008-10-23 Dsm Ip Assets B.V. Transaminase-based processes for preparation of pregabalin
CN102341494A (zh) * 2009-01-08 2012-02-01 科德克希思公司 转氨酶多肽

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB834100A (en) 1957-10-26 1960-05-04 Eastman Kodak Co Improvements in the preparation of mixed aldols
US4239636A (en) * 1978-10-23 1980-12-16 Exxon Research & Engineering Co. Thio-bis-(alkyl lactone acid esters) and thio-bis-(hydrocarbyl diacid esters) are useful additives for lubricating compositions
US6197819B1 (en) 1990-11-27 2001-03-06 Northwestern University Gamma amino butyric acid analogs and optical isomers
JPH06107597A (ja) * 1992-03-12 1994-04-19 Noguchi Kenkyusho (R)−α−ヒドロキシ−β,γ−不飽和エステルの製造法
US5268387A (en) * 1992-04-24 1993-12-07 Allergan, Inc. Pharmaceutical compositions and method for administering 3 and 4-substituted 2(5H)-furanones to a mammal for inhibiting bone loss
CN1106411C (zh) * 1995-11-07 2003-04-23 美国3M公司 引发剂系统和由其制成的粘合剂组合物
KR100491282B1 (ko) 1996-07-24 2005-05-24 워너-램버트 캄파니 엘엘씨 통증 치료용 이소부틸가바 및 그의 유도체
SE9801992D0 (sv) * 1998-06-04 1998-06-04 Astra Ab New 3-aryl-2-hydroxypropionic acid derivative I
MX2007012606A (es) * 2005-04-11 2008-01-11 Teva Pharma Proceso para elaborar (s)-pregabalina.
CA2618057A1 (en) * 2005-08-11 2007-02-22 Vertex Pharmaceuticals Incorporated Modulators of cystic fibrosis transmembrane conductance regulator
KR100846419B1 (ko) * 2007-08-10 2008-07-15 한국과학기술원 프레가발린의 신규한 제조 방법
CN101362696A (zh) * 2008-09-27 2009-02-11 开原亨泰精细化工厂 3-氨甲基-5-甲基己酸即混旋普瑞巴林的制备新方法
WO2011086565A1 (en) 2010-01-15 2011-07-21 Lupin Limited Method for preparation of enantiomerically enriched and/or racemic gamma-amino acids

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1649827A (zh) * 2002-04-30 2005-08-03 沃尼尔·朗伯有限责任公司 高度官能化γ-丁内酰胺和γ-氨基酸的制备方法
WO2008127646A2 (en) * 2007-04-11 2008-10-23 Dsm Ip Assets B.V. Transaminase-based processes for preparation of pregabalin
CN102341494A (zh) * 2009-01-08 2012-02-01 科德克希思公司 转氨酶多肽

Also Published As

Publication number Publication date
BR112015024859A2 (pt) 2017-10-10
CN107746834A (zh) 2018-03-02
CN105051022A (zh) 2015-11-11
MX2015013589A (es) 2016-06-23
CA2905411A1 (en) 2014-10-02
JP2016516744A (ja) 2016-06-09
CN107556273A (zh) 2018-01-09
EP2978748B1 (en) 2017-05-10
EP2978748A1 (en) 2016-02-03
AU2016203782B2 (en) 2017-06-01
CY1118945T1 (el) 2018-01-10
RU2017125261A (ru) 2019-01-31
KR20150121202A (ko) 2015-10-28
DK2978748T3 (en) 2017-07-24
IL241438A0 (en) 2015-11-30
EP3216863A1 (en) 2017-09-13
AU2014240833B2 (en) 2016-07-07
ZA201506798B (en) 2019-05-29
BR122017006144A2 (pt) 2019-09-03
SG11201506998XA (en) 2015-10-29
PL2978748T3 (pl) 2017-09-29
ES2630128T3 (es) 2017-08-18
RU2628298C2 (ru) 2017-08-15
RU2015138545A (ru) 2017-05-03
HUE034834T2 (en) 2018-03-28
AU2016203782A1 (en) 2016-06-23
HK1213882A1 (zh) 2016-07-15
SI2978748T1 (sl) 2017-07-31
AU2014240833A1 (en) 2015-10-01
PT2978748T (pt) 2017-07-06
WO2014155291A1 (en) 2014-10-02
US20160024540A1 (en) 2016-01-28

Similar Documents

Publication Publication Date Title
CN105051022B (zh) 用于制备普瑞巴林的方法和中间体
MXPA02007307A (es) Sintesis asimetrica de pregabalin.
TW201323406A (zh) 製備β3-激動劑及中間物之方法
US20240150344A1 (en) Process for producing acyloxymethyl esters of (4s)-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridin-3-carboxylic acid
CN107074761A (zh) ε‑己内酰胺的制造方法
JP2017105836A (ja) cis−5−ヒドロキシ−2−ピペリジンカルボン酸誘導体の製造方法およびcis−5−ヒドロキシ−2−ピペリジンカルボン酸の精製方法
US20110257401A1 (en) Process for producing optically active carboxylic acid
JP2021520807A (ja) 4−シアノ置換1−アミノインダンおよびオザニモドのエナンチオ選択的生体触媒調製
JP2011236212A (ja) スタチンの調製方法
HK1213882B (en) Process and intermediates for the preparation of pregabalin
AU2015308035B2 (en) Improved process for the preparation of Lacosamide and its novel intermediate
WO2012025861A1 (en) Process for the preparation of ( s ) - 3 - cyano - 5 - methylhexanoic acid derivatives adn of pregabalin
US20080249310A1 (en) Process For the Preparation of (2R,3R)-2-Hydroxy-3-Amino-3-Aryl-Propionamide and (2R,3R)-2-Hydroxy-3-Amino-3-Aryl-Propionic Acid Alkyl Ester
US8524913B2 (en) Process for production of α-trifluoromethyl-β-substituted-β-amino acid
MX2008016121A (es) Sintesis estereoselectiva de (s)-1-metil-3-fenilpiperazina.
US7671231B2 (en) Process for making amino acids
JP2018512398A (ja) ジアミノブタンの調製のためのプロセス
JPWO2014200094A1 (ja) 光学活性アルコール化合物の製造方法
KR20090023828A (ko) 2-설포닐옥시-1-(4-하이드록시페닐)에탄올 유도체의 제조방법

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1213882

Country of ref document: HK

GR01 Patent grant
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1213882

Country of ref document: HK

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20171027

Termination date: 20190325

CF01 Termination of patent right due to non-payment of annual fee